[HTML][HTML] Predicting Vaccine Effectiveness for Hospitalization and Symptomatic Disease for Novel SARS-CoV-2 Variants Using Neutralizing Antibody Titers
BJ Gardner, AM Kilpatrick - Viruses, 2024 - mdpi.com
The emergence of new virus variants, including the Omicron variant (B. 1.1. 529) of SARS-
CoV-2, can lead to reduced vaccine effectiveness (VE) and the need for new vaccines or …
CoV-2, can lead to reduced vaccine effectiveness (VE) and the need for new vaccines or …
[HTML][HTML] Adaptive immune responses to two-dose COVID-19 vaccine series in healthy Canadian adults≥ 50 years: a prospective, observational cohort study
GN Gaultier, B McMillan, C Poloni, M Lo, B Cai… - Scientific Reports, 2024 - nature.com
To evaluate immune responses to COVID-19 vaccines in adults aged 50 years and older,
spike protein (S)-specific antibody concentration, avidity, and function (via angiotensin …
spike protein (S)-specific antibody concentration, avidity, and function (via angiotensin …
[PDF][PDF] Aus der Klinik und Poliklinik für Kinder-und Jugendmedizin der Universitätsmedizin der Johannes Gutenberg-Universität Mainz
LN Stöhr - openscience.ub.uni-mainz.de
0 Aus der Klinik und Poliklinik für Kinder- und Jugendmedizin der Universitätsmedizin der
Johannes Gutenberg-Universität Main Page 1 0 Aus der Klinik und Poliklinik für Kinder- und …
Johannes Gutenberg-Universität Main Page 1 0 Aus der Klinik und Poliklinik für Kinder- und …